Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterResearch Letter

Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study

Luis M. Amezcua-Guerra, Mauricio Mora-Ramirez, Gonzalo Vancini, Valentín Jimenez-Rojas and Ricardo Márquez-Velasco
The Journal of Rheumatology May 2022, 49 (5) 542-544; DOI: https://doi.org/10.3899/jrheum.211156
Luis M. Amezcua-Guerra
1Immunology Department, Instituto Nacional de Cardiología Ignacio Chavez;
2Health Care Department, Universidad Autónoma Metropolitana–Xochimilco, Mexico City, Mexico.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis M. Amezcua-Guerra
Mauricio Mora-Ramirez
1Immunology Department, Instituto Nacional de Cardiología Ignacio Chavez;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mauricio Mora-Ramirez
Gonzalo Vancini
1Immunology Department, Instituto Nacional de Cardiología Ignacio Chavez;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentín Jimenez-Rojas
1Immunology Department, Instituto Nacional de Cardiología Ignacio Chavez;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Márquez-Velasco
1Immunology Department, Instituto Nacional de Cardiología Ignacio Chavez;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ricardo Márquez-Velasco
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 49 no. 5 542-544
DOI 
https://doi.org/10.3899/jrheum.211156
PubMed 
35293330

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online May 1, 2022.

Article Versions

  • Latest version (March 15, 2022 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2022 The Journal of Rheumatology

Author Information

  1. Luis M. Amezcua-Guerra, MD, PhD1,2⇑,
  2. Mauricio Mora-Ramirez, MD1,
  3. Gonzalo Vancini, MD1,
  4. Valentín Jimenez-Rojas, BS1 and
  5. Ricardo Márquez-Velasco, PhD1
  1. 1Immunology Department, Instituto Nacional de Cardiología Ignacio Chavez;
  2. 2Health Care Department, Universidad Autónoma Metropolitana–Xochimilco, Mexico City, Mexico.
  1. Address correspondence to Dr. L.M. Amezcua-Guerra, Instituto Nacional de Cardiología, Juan Badiano 1, Sección XVI, 14080 Tlalpan, Mexico City, Mexico. Email: lmamezcuag@gmail.com.

Article usage

Article usage: March 2022 to May 2022

AbstractFullPdf
Mar 2022476096
Apr 2022123635
May 2022203104378

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 49, Issue 5
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study
Luis M. Amezcua-Guerra, Mauricio Mora-Ramirez, Gonzalo Vancini, Valentín Jimenez-Rojas, Ricardo Márquez-Velasco
The Journal of Rheumatology May 2022, 49 (5) 542-544; DOI: 10.3899/jrheum.211156

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study
Luis M. Amezcua-Guerra, Mauricio Mora-Ramirez, Gonzalo Vancini, Valentín Jimenez-Rojas, Ricardo Márquez-Velasco
The Journal of Rheumatology May 2022, 49 (5) 542-544; DOI: 10.3899/jrheum.211156
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study
  • Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France
  • Immunogenicity of COVID-19 Vaccination in Patients With Ankylosing Spondylitis: A Monocentric Prospective Belgian Cohort Study
Show more Research Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire